Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹-104 Cr₹-75 Cr₹124 Cr₹193 Cr₹237 Cr
Adjustment ₹250 Cr₹184 Cr₹138 Cr₹121 Cr₹87 Cr
Changes In working Capital ₹55 Cr₹2.79 Cr₹-88 Cr₹-73 Cr₹-109 Cr
Cash Flow after changes in Working Capital ₹201 Cr₹111 Cr₹173 Cr₹240 Cr₹215 Cr
Cash Flow from Operating Activities ₹192 Cr₹95 Cr₹155 Cr₹179 Cr₹174 Cr
Cash Flow from Investing Activities ₹-102 Cr₹-339 Cr₹-433 Cr₹-208 Cr₹-121 Cr
Cash Flow from Financing Activities ₹-77 Cr₹241 Cr₹280 Cr₹23 Cr₹-44 Cr
Net Cash Inflow / Outflow ₹14 Cr₹-2.75 Cr₹3.31 Cr₹-6.54 Cr₹8.05 Cr
Opening Cash & Cash Equivalents ₹12 Cr₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations --₹0.62 Cr--
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹26 Cr₹12 Cr₹15 Cr₹11 Cr₹17 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,975.7 Cr -5.1% -15.7% -23.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,803.0 Cr 0.2% -5.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹253,833.0 Cr 4.9% -0.5% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,461.0 Cr -1.1% -8.5% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,463.0 Cr 7.8% 11% 1.2% Stock Analytics
CIPLA ₹109,870.0 Cr 2.3% -2.7% -18.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-5.1%

-15.7%

-23.4%

SENSEX

-0.6%

-0.5%

-13.2%


You may also like the below Video Courses